Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma

International Journal of Cancer

Volumn 86, Issue 5, 2000, Pages 684-689

  Yamaguchi, Kengo ^a,b   Wu, Li ^a   Caballero, Otávia L ^a   Hibi, Kenji ^a   Trink, Barry ^a   Resto, Vicente ^a   Cairns, Paul ^a,c   Okami, Kenji ^a,d   Koch, Wayne M ^a   Sidransky, David ^a   Jen, Jin ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c FOX CHASE CANCER CENTER   (United States)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P40; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE LOCUS; GENE MAPPING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; YEAST ARTIFICIAL CHROMOSOME;

ALLELES; CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; EXONS; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRONS; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; PHOSPHOPROTEINS; PROTEINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034099274     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M     Document Type: Article

References (22)

1. AL-JEHANI, R.M.A., WELLS, D., FOX, M. and PARRINGTON, J.M., Correlation of loss of heterozygosity with cytogenetic analysis using G-banding and fluorescence in situ hybridization in aneuploid cultures from two human testicular germ-cell tumors. Cancer Genet Cytogenet., 85, 26-36 (1995).
2. BOCKMÜHL, U., SCHWENDEL, A., DIETEL, M. and PETERSEN, I., Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res., 56, 5325-5329 (1996).
3. BRASS, N., HECKEL, D., SAHIN, U., PFREUNDSCHUH, M., SYBRECHT, G.W. and MEESE, E., Translation initiation factor elF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum. mol. Genet., 6, 33-39 (1997a).
4. BRASS, N., RÄCZ, A., HECKEL, D., REMBERGER, K., SYBRECHT, G.W. and MEESE, E.U., Amplification of the gene BCHE and SLC2A2 in 40% of squamous cell carcinoma of lung. Cancer Res., 57, 2290-2294 (1997b).
5. CAIRNS, P., OKAMI, K., HALACHMI, S., HALACHMI N., ESTELLER, M., HERMAN, J.S., JEN, J., ISAACS, W.B., BOVA, G.S. and SIDRANSKY, D., Frequent inactivation of PTEN/MMAC 1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
6. CALIFANO, L., RIET, P.D.R., WESTRA, W., NAUROZ, H., CLAYMAN, G., PIANTADOSI, S., CORIO, R., LEE, D., GREENBERG, B., KOCK, W. and SIDRANSKY, D., Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56, 2488-2492 (1996).
7. HAGIWARA, K., MCMENAMIN, M.G., MIURA, K. and HARRIS, C., Mutational analysis of the p63/p731/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res., 59, 4165-9 (1999).
8. HIBI, K., TRINK, B., PATTURAJAN, M., WESTRA, W.H., CABALLERO, O.L., HILL, D.E., RATOVISKI, E.A., JEN, J. and SIDRANSKY, D., AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA, in press (2000).
9. HUGHSON, M.H., DICKMAN, K., BIGLER, S.A., MELOI, A.M. and SANDBERG, A.A., Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. Cancer Genet. Cytogenet., 106, 93-104 (1998).
10. IMREH, S., KOST-ALOMOVA, M., KHOLODNYUK, I., YANG, Y., SZELES, A., KISS, H., LIU, Y., FOSTER, K., ZABAROVSKY, E., STANBRIDGE, E. and KLEIN, G., Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth. Genes Chromosomes Cancer, 20, 224-233 (1997).
11. MANIATIS, T., FRITSCH, E.F. and SAMBROOK, J., Molecular cloling: a laboratory manual, (2nd ed.), Cold Spring Harbor Laboratory, New York (1989).
12. MILLS, A.A., ZHENG, B., WANG, X.J., VOGEL, H., ROOP, D.R. and BRADLEY, A., p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (Lond.), 398, 708-713 (1999).
13. MURPHY, D.S., HOARE, S.F., GOING, J.J., MALLON, E.E.A., GEORGE, W.D., KAYE, S.B., BROWN, R., BLACK, D.M. and KEITH, W.N., Characterization of extensive genetic alteration in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J. natl. Cancer Inst. 87, 1694-1704 (1995).
14. OKAMI, K., CAIRNS, P., WESTRA, W.H., LINN, J.F., AHRENDT, S.A., WU, L., SIDRANSKY, D and JEN, J., Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int. J. Cancer, 74, 588-592 (1997).
15. OSADA, M., OHBA, M., KAWAHARA, C., ISHIOKA, C., KANAMARU, R., KATOH, I., IKAWA, Y., NIMURA, Y., NAKAGAWARA, A., OBINATA, M. IKAWA, S., Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature (Med.), 4, 839-843 (1998).
16. SHAYESTEH, L., LU, Y., KUO, W.L., BALDOCCHI, R., GODFREY, T., COLLINS, C., PINKEL, D., POWEL, B., MILLS, G.B. and GRAY, J.W., P1K3CA is implicated as an oncogene in ovarian cancer. Nature (Genet.), 21, 99-102 (1999).
17. SODER, A.I., HOARE, S.F., MUIR, S., GOING, J.J., PARKINSON, E.K. and KEITH, W.N., Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene, 14, 1013-1021 (1997).
18. SPEICHER, M.R., HOWE, C., CROTTY, P., DU MANIOR, S., COSTA, J. and WARD, D.C., Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinoma. Cancer Res., 55, 1010-1013 (1995).
19. TANI, M., SHIMIZU, K., KAWAHARA, C., KOHNO, T., ISHIMOTO, T., IKAWA, S. and YOKOTA, J., Mutation and expression of the p51 gene in human lung cancer. Neoplasia, 1, 71-79 (1999).
20. TRINK, B., OKAMI, K., WU, L., SRIURANPONG, V., JEN, J. and SIDRANSKY, D., A new human p53 homologue. Nature (Med.), 4, 747-748 (1998).
21. YANG, A., KAGHAD, M., WANG, Y., GILLET, E., FLEMING, M.D., DÖTSCH, V., ANDREWS, N.C., CAPUT, D. and MCKEON, F., p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-316 (1998).
22. YANG, A, SCHWETTZER, R., SUN, D., KAGHAD, M., WALKER, M., BRONSON, R.T., TABIN, C., SHARPE, A., CAPUT, D., CRUM, C. and MCKEON, F., p63 is essential for regenerative proliferation on limb, craniofacial and epithelial development. Nature (Lond.), 398, 714-718 (1999).